{"id":27295,"date":"2026-01-16T14:52:31","date_gmt":"2026-01-16T17:52:31","guid":{"rendered":"https:\/\/sobelconsult.com\/the-new-fda-cosmetics-recalls-landscape\/"},"modified":"2026-02-05T15:33:21","modified_gmt":"2026-02-05T18:33:21","slug":"recall-cosmeticos-fda","status":"publish","type":"post","link":"https:\/\/sobelconsult.com\/pt-br\/recall-cosmeticos-fda\/","title":{"rendered":"News: o novo cen\u00e1rio de recall de cosm\u00e9ticos no FDA e mais"},"content":{"rendered":"\n<p>As atualiza\u00e7\u00f5es regulat\u00f3rias recentes mostram um movimento claro das autoridades globais: mais rigor t\u00e9cnico, mais transpar\u00eancia e maior expectativa de controle ao longo de todo o ciclo de vida dos produtos. <strong>Um exemplo est\u00e1 no recall de cosm\u00e9ticos<\/strong>, que passa a ganhar um novo <a href=\"https:\/\/sobelconsult.com\/pt-br\/registro-de-cosmeticos-estados-unidos\/\">peso regulat\u00f3rio nos Estados Unidos<\/a>.<\/p>\n\n<p>Neste artigo, reunimos os principais destaques regulat\u00f3rios recentes envolvendo FDA, Uni\u00e3o Europeia e China. Entenda <strong>como esse cen\u00e1rio pode impactar empresas que atuam em mercados altamente regulados!<\/strong> <\/p>\n\n<h2 class=\"wp-block-heading\" id=\"h-fda-issues-draft-guidance-on-mandatory-cosmetics-recalls\"><strong>FDA publica draft guidance sobre recalls obrigat\u00f3rios de cosm\u00e9ticos<\/strong><\/h2>\n\n<p>O <a href=\"https:\/\/www.fda.gov\/cosmetics\/cosmetics-news-events\/fda-issues-draft-guidance-industry-questions-and-answers-regarding-mandatory-cosmetics-recalls\">Food and Drug Administration publicou um draft guidance<\/a> intitulado <em>&#8220;Questions and Answers Regarding Mandatory Cosmetics Recalls: Orienta\u00e7\u00e3o para o setor&#8221;.<\/em> O objetivo \u00e9 de esclarecer <strong>como a ag\u00eancia pretende exercer sua autoridade legal para determinar recalls obrigat\u00f3rios,<\/strong> conforme previsto no MoCRA.<\/p>\n\n<p>O documento detalha crit\u00e9rios, etapas do processo e expectativas regulat\u00f3rias aplic\u00e1veis quando um produto cosm\u00e9tico adulterado ou rotulado de forma inadequada representa risco s\u00e9rio \u00e0 sa\u00fade do consumidor.<\/p>\n\n<p>Na pr\u00e1tica, o material <strong>sinaliza uma mudan\u00e7a relevante na forma como o recall de cosm\u00e9ticos deve ser tratado pelas empresas.<\/strong> Tamb\u00e9m refor\u00e7a que a atua\u00e7\u00e3o do FDA n\u00e3o depende mais exclusivamente de a\u00e7\u00f5es volunt\u00e1rias do fabricante.<\/p>\n\n<p>Embora o guidance ainda esteja em vers\u00e3o preliminar, ele reflete o entendimento atual do FDA sobre a aplica\u00e7\u00e3o de sua autoridade legal. Isso indica expectativas mais elevadas quanto \u00e0 maturidade dos sistemas de p\u00f3s-mercado, \u00e0 gest\u00e3o de reclama\u00e7\u00f5es, \u00e0 rastreabilidade de produtos e \u00e0 capacidade de resposta r\u00e1pida diante de eventos adversos. <\/p>\n\n<p>Para empresas que fabricam, exportam ou comercializam cosm\u00e9ticos nos Estados Unidos, esse cen\u00e1rio refor\u00e7a a necessidade de revisar processos internos, planos de conting\u00eancia e documenta\u00e7\u00e3o t\u00e9cnica. O recall de cosm\u00e9ticos deixa de ser um evento excepcional e passa a integrar o planejamento regulat\u00f3rio cont\u00ednuo, com impacto direto na gest\u00e3o de riscos e na prote\u00e7\u00e3o da marca. <\/p>\n\n<h2 class=\"wp-block-heading\" id=\"h-european-union-considers-simplifying-mdr-requirements\"><strong>Uni\u00e3o Europeia avalia simplifica\u00e7\u00e3o do MDR<\/strong><\/h2>\n\n<p>Al\u00e9m dos recalls de cosm\u00e9ticos da FDA, o ambiente regulat\u00f3rio europeu tamb\u00e9m est\u00e1 evoluindo. A Comiss\u00e3o Europeia <a href=\"https:\/\/www.medtechdive.com\/news\/eu-proposal-simplify-mdr\/808398\/\">prop\u00f4s a simplifica\u00e7\u00e3o de determinados requisitos do Regulamento de Dispositivos M\u00e9dicos (MDR)<\/a>. O objetivo \u00e9 reduzir a carga regulat\u00f3ria sem comprometer a seguran\u00e7a dos produtos. <\/p>\n\n<p>A iniciativa pode influenciar prazos de avalia\u00e7\u00e3o, obriga\u00e7\u00f5es de p\u00f3s-mercado e a atua\u00e7\u00e3o dos Notified Bodies.<\/p>\n\n<p>Embora <strong>o foco seja dispositivos m\u00e9dicos e IVDs<\/strong>, esse movimento refor\u00e7a uma tend\u00eancia comum tamb\u00e9m observada no setor de cosm\u00e9ticos: ajustes regulat\u00f3rios para equilibrar controle, previsibilidade e efici\u00eancia.<\/p>\n\n<h2 class=\"wp-block-heading\" id=\"h-mdcg-reinforces-post-market-surveillance-expectations\"><strong>MDCG refor\u00e7a expectativas de vigil\u00e2ncia p\u00f3s-mercado<\/strong><\/h2>\n\n<p>Complementando esse cen\u00e1rio, o Medical Device Coordination Group (MDCG) publicou <a href=\"https:\/\/www.raps.org\/news-and-articles\/news-articles\/2026\/1\/mdcg-outlines-postmarket-surveillance-expectations\">orienta\u00e7\u00f5es atualizadas sobre a vigil\u00e2ncia p\u00f3s-comercializa\u00e7\u00e3o na Europa<\/a>.<\/p>\n\n<p>O documento enfatiza a coleta sistem\u00e1tica de dados, a an\u00e1lise cont\u00ednua de riscos e a coer\u00eancia entre PMS, PMCF e gest\u00e3o de riscos.<\/p>\n\n<p><strong>A mensagem \u00e9 clara: <\/strong>autoridades esperam abordagens estruturadas e proativas de p\u00f3s-mercado.<\/p>\n\n<h2 class=\"wp-block-heading\" id=\"h-china-reviews-requirements-for-new-cosmetic-ingredients\"><strong>China revisa requisitos para novos ingredientes cosm\u00e9ticos<\/strong><\/h2>\n\n<p>Enquanto temos recall de cosm\u00e9ticos em um mercado <strong>na \u00c1sia,  <\/strong>a National Medical Products Administration (NMPA) <a href=\"https:\/\/cosmetic.chemlinked.com\/news\/cosmetic-news\/chinas-nmpa-seeks-public-feedback-on-revised-nci-dossier\">abriu uma consulta p\u00fablica para revisar os requisitos do dossi\u00ea para Novos Ingredientes Cosm\u00e9ticos (NCI<\/a>).<\/p>\n\n<figure class=\"wp-block-image aligncenter size-full\"><img fetchpriority=\"high\" decoding=\"async\" width=\"1000\" height=\"714\" src=\"https:\/\/sobelconsult.com\/wp-content\/uploads\/2025\/07\/photo-cosmetics-services.jpg\" alt=\"M&#xE3;os femininas escrevendo com uma caneta em um tubo contendo um l&#xED;quido amarelo. Abaixo, relat&#xF3;rios impressos. Na mesa ao lado, h&#xE1; um laptop e outros instrumentos de an&#xE1;lise.  \" class=\"wp-image-10787\" srcset=\"https:\/\/sobelconsult.com\/wp-content\/uploads\/2025\/07\/photo-cosmetics-services.jpg 1000w, https:\/\/sobelconsult.com\/wp-content\/uploads\/2025\/07\/photo-cosmetics-services-300x214.jpg 300w, https:\/\/sobelconsult.com\/wp-content\/uploads\/2025\/07\/photo-cosmetics-services-768x548.jpg 768w\" sizes=\"(max-width: 1000px) 100vw, 1000px\" \/><\/figure>\n\n<p>As mudan\u00e7as propostas podem afetar dados exigidos, prazos de avalia\u00e7\u00e3o e estrat\u00e9gias de entrada no mercado chin\u00eas.<\/p>\n\n<p>Para marcas que avaliam expans\u00e3o internacional, <strong>esse movimento indica um esfor\u00e7o das autoridades chinesas para ajustar processos regulat\u00f3rios, ampliar previsibilidade e, ao mesmo tempo, manter controle sobre seguran\u00e7a e inova\u00e7\u00e3o.<\/strong><\/p>\n\n<h2 class=\"wp-block-heading\" id=\"h-a-global-shift-toward-greater-regulatory-accountability\"><strong>Um cen\u00e1rio global de maior responsabilidade regulat\u00f3ria<\/strong><\/h2>\n\n<p>Quando analisadas em conjunto, essas atualiza\u00e7\u00f5es revelam uma tend\u00eancia global: <strong>maior rigor t\u00e9cnico, expectativas claras sobre p\u00f3s-mercado e fortalecimento das ferramentas regulat\u00f3rias das autoridades<\/strong>. No caso dos Estados Unidos, isso se traduz diretamente em uma abordagem mais estruturada e menos reativa ao recall de cosm\u00e9ticos, exigindo preparo pr\u00e9vio das empresas.<\/p>\n\n<p>Acompanhar essas mudan\u00e7as e incorpor\u00e1-las ao planejamento regulat\u00f3rio \u00e9 parte essencial da estrat\u00e9gia de conformidade. Para isso, manter processos atualizados, documenta\u00e7\u00e3o consistente e decis\u00f5es bem fundamentadas ajudam a reduzir riscos, evitar atrasos e fortalecer a sustentabilidade regulat\u00f3ria dos produtos no mercado. <\/p>\n\n<p>Se voc\u00ea quiser receber atualiza\u00e7\u00f5es como essas regularmente, assine gratuitamente o <a href=\"https:\/\/sobelconsult.com\/?popup=810\">Sobel News Round Up<\/a> e mantenha-se informado sobre o que pode afetar sua empresa.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Enquanto o FDA fortalece o recall de cosm\u00e9ticos, UE e China fazem atualiza\u00e7\u00f5es regulat\u00f3rias importantes.<\/p>\n","protected":false},"author":16,"featured_media":27282,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[308],"tags":[329,127,128,156,309],"class_list":["post-27295","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-noticias-pt-br","tag-china-pt-br","tag-cosmeticos-pt-br","tag-europa-pt-br","tag-fda-pt-br","tag-noticias-pt-br"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v26.3 (Yoast SEO v26.8) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>News: o novo cen\u00e1rio de recall de cosm\u00e9ticos no FDA e mais - Sobel<\/title>\n<meta name=\"description\" content=\"Enquanto o FDA fortalece o recall de cosm\u00e9ticos, UE e China fazem atualiza\u00e7\u00f5es regulat\u00f3rias importantes.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/sobelconsult.com\/pt-br\/recall-cosmeticos-fda\/\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"News: o novo cen\u00e1rio de recall de cosm\u00e9ticos no FDA e mais\" \/>\n<meta property=\"og:description\" content=\"Enquanto o FDA fortalece o recall de cosm\u00e9ticos, UE e China fazem atualiza\u00e7\u00f5es regulat\u00f3rias importantes.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/sobelconsult.com\/pt-br\/recall-cosmeticos-fda\/\" \/>\n<meta property=\"og:site_name\" content=\"Sobel\" \/>\n<meta property=\"article:published_time\" content=\"2026-01-16T17:52:31+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-02-05T18:33:21+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/sobelconsult.com\/wp-content\/uploads\/2026\/01\/cosmetic-products.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1000\" \/>\n\t<meta property=\"og:image:height\" content=\"667\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Bruna Marzarotto\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Bruna Marzarotto\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. tempo de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/sobelconsult.com\/pt-br\/recall-cosmeticos-fda\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/sobelconsult.com\/pt-br\/recall-cosmeticos-fda\/\"},\"author\":{\"name\":\"Bruna Marzarotto\",\"@id\":\"https:\/\/sobelconsult.com\/pt-br\/#\/schema\/person\/bd2753d272a36eb353492e956e803d3b\"},\"headline\":\"News: o novo cen\u00e1rio de recall de cosm\u00e9ticos no FDA e mais\",\"datePublished\":\"2026-01-16T17:52:31+00:00\",\"dateModified\":\"2026-02-05T18:33:21+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/sobelconsult.com\/pt-br\/recall-cosmeticos-fda\/\"},\"wordCount\":776,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/sobelconsult.com\/pt-br\/#organization\"},\"image\":{\"@id\":\"https:\/\/sobelconsult.com\/pt-br\/recall-cosmeticos-fda\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/sobelconsult.com\/wp-content\/uploads\/2026\/01\/cosmetic-products.jpg\",\"keywords\":[\"China\",\"Cosm\u00e9ticos\",\"Europa\",\"FDA\",\"Not\u00edcias\"],\"articleSection\":[\"Not\u00edcias\"],\"inLanguage\":\"pt-BR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/sobelconsult.com\/pt-br\/recall-cosmeticos-fda\/\",\"url\":\"https:\/\/sobelconsult.com\/pt-br\/recall-cosmeticos-fda\/\",\"name\":\"News: o novo cen\u00e1rio de recall de cosm\u00e9ticos no FDA e mais - Sobel\",\"isPartOf\":{\"@id\":\"https:\/\/sobelconsult.com\/pt-br\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/sobelconsult.com\/pt-br\/recall-cosmeticos-fda\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/sobelconsult.com\/pt-br\/recall-cosmeticos-fda\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/sobelconsult.com\/wp-content\/uploads\/2026\/01\/cosmetic-products.jpg\",\"datePublished\":\"2026-01-16T17:52:31+00:00\",\"dateModified\":\"2026-02-05T18:33:21+00:00\",\"description\":\"Enquanto o FDA fortalece o recall de cosm\u00e9ticos, UE e China fazem atualiza\u00e7\u00f5es regulat\u00f3rias importantes.\",\"breadcrumb\":{\"@id\":\"https:\/\/sobelconsult.com\/pt-br\/recall-cosmeticos-fda\/#breadcrumb\"},\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/sobelconsult.com\/pt-br\/recall-cosmeticos-fda\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\/\/sobelconsult.com\/pt-br\/recall-cosmeticos-fda\/#primaryimage\",\"url\":\"https:\/\/sobelconsult.com\/wp-content\/uploads\/2026\/01\/cosmetic-products.jpg\",\"contentUrl\":\"https:\/\/sobelconsult.com\/wp-content\/uploads\/2026\/01\/cosmetic-products.jpg\",\"width\":1000,\"height\":667,\"caption\":\"cosmetic products over a table.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/sobelconsult.com\/pt-br\/recall-cosmeticos-fda\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/sobelconsult.com\/pt-br\/home\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"News: o novo cen\u00e1rio de recall de cosm\u00e9ticos no FDA e mais\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/sobelconsult.com\/pt-br\/#website\",\"url\":\"https:\/\/sobelconsult.com\/pt-br\/\",\"name\":\"Sobel\",\"description\":\"Regulatory Consultancy\",\"publisher\":{\"@id\":\"https:\/\/sobelconsult.com\/pt-br\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/sobelconsult.com\/pt-br\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-BR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/sobelconsult.com\/pt-br\/#organization\",\"name\":\"Sobel\",\"url\":\"https:\/\/sobelconsult.com\/pt-br\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\/\/sobelconsult.com\/pt-br\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/sobelconsult.com\/wp-content\/uploads\/2024\/07\/Logo-Oficial-Website-White.png\",\"contentUrl\":\"https:\/\/sobelconsult.com\/wp-content\/uploads\/2024\/07\/Logo-Oficial-Website-White.png\",\"width\":741,\"height\":290,\"caption\":\"Sobel\"},\"image\":{\"@id\":\"https:\/\/sobelconsult.com\/pt-br\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/sobelconsult.com\/pt-br\/#\/schema\/person\/bd2753d272a36eb353492e956e803d3b\",\"name\":\"Bruna Marzarotto\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\/\/sobelconsult.com\/pt-br\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/0739b908e11e6bd3813c8c44709242bf98c50500b85aa4103b34b62b248ec195?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/0739b908e11e6bd3813c8c44709242bf98c50500b85aa4103b34b62b248ec195?s=96&d=mm&r=g\",\"caption\":\"Bruna Marzarotto\"}}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"News: o novo cen\u00e1rio de recall de cosm\u00e9ticos no FDA e mais - Sobel","description":"Enquanto o FDA fortalece o recall de cosm\u00e9ticos, UE e China fazem atualiza\u00e7\u00f5es regulat\u00f3rias importantes.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/sobelconsult.com\/pt-br\/recall-cosmeticos-fda\/","og_locale":"pt_BR","og_type":"article","og_title":"News: o novo cen\u00e1rio de recall de cosm\u00e9ticos no FDA e mais","og_description":"Enquanto o FDA fortalece o recall de cosm\u00e9ticos, UE e China fazem atualiza\u00e7\u00f5es regulat\u00f3rias importantes.","og_url":"https:\/\/sobelconsult.com\/pt-br\/recall-cosmeticos-fda\/","og_site_name":"Sobel","article_published_time":"2026-01-16T17:52:31+00:00","article_modified_time":"2026-02-05T18:33:21+00:00","og_image":[{"width":1000,"height":667,"url":"https:\/\/sobelconsult.com\/wp-content\/uploads\/2026\/01\/cosmetic-products.jpg","type":"image\/jpeg"}],"author":"Bruna Marzarotto","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Bruna Marzarotto","Est. tempo de leitura":"4 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/sobelconsult.com\/pt-br\/recall-cosmeticos-fda\/#article","isPartOf":{"@id":"https:\/\/sobelconsult.com\/pt-br\/recall-cosmeticos-fda\/"},"author":{"name":"Bruna Marzarotto","@id":"https:\/\/sobelconsult.com\/pt-br\/#\/schema\/person\/bd2753d272a36eb353492e956e803d3b"},"headline":"News: o novo cen\u00e1rio de recall de cosm\u00e9ticos no FDA e mais","datePublished":"2026-01-16T17:52:31+00:00","dateModified":"2026-02-05T18:33:21+00:00","mainEntityOfPage":{"@id":"https:\/\/sobelconsult.com\/pt-br\/recall-cosmeticos-fda\/"},"wordCount":776,"commentCount":0,"publisher":{"@id":"https:\/\/sobelconsult.com\/pt-br\/#organization"},"image":{"@id":"https:\/\/sobelconsult.com\/pt-br\/recall-cosmeticos-fda\/#primaryimage"},"thumbnailUrl":"https:\/\/sobelconsult.com\/wp-content\/uploads\/2026\/01\/cosmetic-products.jpg","keywords":["China","Cosm\u00e9ticos","Europa","FDA","Not\u00edcias"],"articleSection":["Not\u00edcias"],"inLanguage":"pt-BR"},{"@type":"WebPage","@id":"https:\/\/sobelconsult.com\/pt-br\/recall-cosmeticos-fda\/","url":"https:\/\/sobelconsult.com\/pt-br\/recall-cosmeticos-fda\/","name":"News: o novo cen\u00e1rio de recall de cosm\u00e9ticos no FDA e mais - Sobel","isPartOf":{"@id":"https:\/\/sobelconsult.com\/pt-br\/#website"},"primaryImageOfPage":{"@id":"https:\/\/sobelconsult.com\/pt-br\/recall-cosmeticos-fda\/#primaryimage"},"image":{"@id":"https:\/\/sobelconsult.com\/pt-br\/recall-cosmeticos-fda\/#primaryimage"},"thumbnailUrl":"https:\/\/sobelconsult.com\/wp-content\/uploads\/2026\/01\/cosmetic-products.jpg","datePublished":"2026-01-16T17:52:31+00:00","dateModified":"2026-02-05T18:33:21+00:00","description":"Enquanto o FDA fortalece o recall de cosm\u00e9ticos, UE e China fazem atualiza\u00e7\u00f5es regulat\u00f3rias importantes.","breadcrumb":{"@id":"https:\/\/sobelconsult.com\/pt-br\/recall-cosmeticos-fda\/#breadcrumb"},"inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/sobelconsult.com\/pt-br\/recall-cosmeticos-fda\/"]}]},{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/sobelconsult.com\/pt-br\/recall-cosmeticos-fda\/#primaryimage","url":"https:\/\/sobelconsult.com\/wp-content\/uploads\/2026\/01\/cosmetic-products.jpg","contentUrl":"https:\/\/sobelconsult.com\/wp-content\/uploads\/2026\/01\/cosmetic-products.jpg","width":1000,"height":667,"caption":"cosmetic products over a table."},{"@type":"BreadcrumbList","@id":"https:\/\/sobelconsult.com\/pt-br\/recall-cosmeticos-fda\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/sobelconsult.com\/pt-br\/home\/"},{"@type":"ListItem","position":2,"name":"News: o novo cen\u00e1rio de recall de cosm\u00e9ticos no FDA e mais"}]},{"@type":"WebSite","@id":"https:\/\/sobelconsult.com\/pt-br\/#website","url":"https:\/\/sobelconsult.com\/pt-br\/","name":"Sobel","description":"Regulatory Consultancy","publisher":{"@id":"https:\/\/sobelconsult.com\/pt-br\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/sobelconsult.com\/pt-br\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-BR"},{"@type":"Organization","@id":"https:\/\/sobelconsult.com\/pt-br\/#organization","name":"Sobel","url":"https:\/\/sobelconsult.com\/pt-br\/","logo":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/sobelconsult.com\/pt-br\/#\/schema\/logo\/image\/","url":"https:\/\/sobelconsult.com\/wp-content\/uploads\/2024\/07\/Logo-Oficial-Website-White.png","contentUrl":"https:\/\/sobelconsult.com\/wp-content\/uploads\/2024\/07\/Logo-Oficial-Website-White.png","width":741,"height":290,"caption":"Sobel"},"image":{"@id":"https:\/\/sobelconsult.com\/pt-br\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/sobelconsult.com\/pt-br\/#\/schema\/person\/bd2753d272a36eb353492e956e803d3b","name":"Bruna Marzarotto","image":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/sobelconsult.com\/pt-br\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/0739b908e11e6bd3813c8c44709242bf98c50500b85aa4103b34b62b248ec195?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/0739b908e11e6bd3813c8c44709242bf98c50500b85aa4103b34b62b248ec195?s=96&d=mm&r=g","caption":"Bruna Marzarotto"}}]}},"_links":{"self":[{"href":"https:\/\/sobelconsult.com\/pt-br\/wp-json\/wp\/v2\/posts\/27295","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/sobelconsult.com\/pt-br\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/sobelconsult.com\/pt-br\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/sobelconsult.com\/pt-br\/wp-json\/wp\/v2\/users\/16"}],"replies":[{"embeddable":true,"href":"https:\/\/sobelconsult.com\/pt-br\/wp-json\/wp\/v2\/comments?post=27295"}],"version-history":[{"count":1,"href":"https:\/\/sobelconsult.com\/pt-br\/wp-json\/wp\/v2\/posts\/27295\/revisions"}],"predecessor-version":[{"id":29020,"href":"https:\/\/sobelconsult.com\/pt-br\/wp-json\/wp\/v2\/posts\/27295\/revisions\/29020"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/sobelconsult.com\/pt-br\/wp-json\/wp\/v2\/media\/27282"}],"wp:attachment":[{"href":"https:\/\/sobelconsult.com\/pt-br\/wp-json\/wp\/v2\/media?parent=27295"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/sobelconsult.com\/pt-br\/wp-json\/wp\/v2\/categories?post=27295"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/sobelconsult.com\/pt-br\/wp-json\/wp\/v2\/tags?post=27295"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}